A Phase I, Open-label, Multicenter, First in Human Study to Evaluate the Safety and Tolerability of HH3806 in Patients with Advanced Malignancies
ACTRN 12622001339741 Brief Summary This is a first in human study of…
Read more arrow_forwardACTRN 12622001339741 Brief Summary This is a first in human study of…
Read more arrow_forwardNCT 05123482 Brief Summary This research study is studying a new compound,…
Read more arrow_forwardNCT 06815575 Brief Summary This is a multi-centre, two-part, open-label, phase 1,…
Read more arrow_forwardNCT 05332574 Brief Summary This is a Phase 1/2 study of GB263T…
Read more arrow_forwardNCT 05920356 Brief Summary The primary objective of this study is…
Read more arrow_forwardNCT 06497556 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 05789082 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05981703 Brief Summary This is an open-label, multicenter, and nonrandomized dose…
Read more arrow_forwardNCT 06875310 Brief Summary This is a trial to evaluate the efficacy,…
Read more arrow_forwardNCT 05094336 Brief Summary The primary objective of Parts 1 and 2…
Read more arrow_forward